Ailawadhi, Sikander <br/><br/>
Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  08 2020 
 - 3969-3978 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-19-1997  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cross-Over Studies<br/>Dexamethasone--administration & dosage<br/>Drug Administration Schedule<br/>Drug Resistance, Neoplasm<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Neoplasm Recurrence, Local--drug therapy<br/>Oligopeptides--administration & dosage<br/>Progression-Free Survival